Advertising Disclaimer
Published online January 3, 2006
PEDIATRICS Vol. 117 No. 2 February 2006, pp. 284-289 (doi:10.1542/peds.2005-0824)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biernath, K. R.
Right arrow Articles by Boyle, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biernath, K. R.
Right arrow Articles by Boyle, C.
Related Collections
Right arrow Dentistry & Otolaryngology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Bacterial Meningitis Among Children With Cochlear Implants Beyond 24 Months After Implantation

Krista R. Biernath, MDa, Jennita Reefhuis, PhDa, Cynthia G. Whitney, MDb, Eric A. Mann, MD, PhDc, Pamela Costa, MAa, John Eichwald, MAa, Coleen Boyle, PhDa

a National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
b National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
c Food and Drug Administration, Rockville, Maryland

Background. More than 11000 children in the United States with severe-to-profound hearing loss have cochlear implants. A 2002 investigation involving pediatric cochlear implant recipients identified meningitis episodes from January 1, 1997, through September 15, 2002. The incidence of pneumococcal meningitis in the cohort was 138.2 cases per 100000 person-years, >30 times higher than that for children in the general US population. Children with implants with positioners were at higher risk than children with other implant models. This higher risk of bacterial meningitis continued for up to 24 months after implantation.

Objective. To evaluate additional reported cases to determine whether the increased rate of bacterial meningitis among children with cochlear implants extended beyond 24 months after implantation.

Methods. Our study population consisted of the cohort of children identified through the 2002 investigation; it included 4265 children who received cochlear implants in the United States between January 1, 1997, and August 6, 2002, and who were <6 years of age at the time of implantation. We calculated updated incidence rates and incidence according to time since implantation.

Results. We identified 12 new episodes of meningitis for 12 children. Eleven of the children had implants with positioners; 2 children died. Six episodes occurred >24 months after implantation. When cases identified in the 2002 and 2004 investigations were combined, the incidence rate of ≥24-months postimplantation bacterial meningitis among children with positioners was 450 cases per 100000 person-years, compared with no cases among children without positioners.

Conclusions. Our updated findings support continued monitoring and prompt treatment of bacterial infections by health care providers and parents of children with cochlear implants. This vigilance remains important beyond 2 years after implantation, particularly among children with positioners. The vaccination recommendations for all children with implants, with and without positioners, and all potential recipients of implants continue to apply.

Key Words: hearing loss • intervention • meningitis • bacterial infections

Abbreviations: FDA—Food and Drug Administration • CDC—Centers for Disease Control and Prevention • CSF—cerebrospinal fluid

Accepted Jun 8, 2005.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Hearing and Hearing Disorders in ChildhoodHome page
O. F. Adunka and C. A. Buchman
Medical and Surgical Evaluation Prior to Pediatric Cochlear Implantation
Hearing and Hearing Disorders in Childhood, March 1, 2009; 19(1): 22 - 31.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. Hjuler, J. Wohlfahrt, M. Staum Kaltoft, A. Koch, R. J. Biggar, and M. Melbye
Risks of Invasive Pneumococcal Disease in Children With Underlying Chronic Diseases
Pediatrics, July 1, 2008; 122(1): e26 - e32.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
H. D. Nelson, C. Bougatsos, and P. Nygren
Universal Newborn Hearing Screening: Systematic Review to Update the 2001 US Preventive Services Task Force Recommendation
Pediatrics, July 1, 2008; 122(1): e266 - e276.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
B. C. Papsin and K. A. Gordon
Cochlear Implants for Children with Severe-to-Profound Hearing Loss
N. Engl. J. Med., December 6, 2007; 357(23): 2380 - 2387.
[Full Text] [PDF]

Home page
 PediatricsHome page
Joint Committee on Infant Hearing
Year 2007 Position Statement: Principles and Guidelines for Early Hearing Detection and Intervention Programs
Pediatrics, October 1, 2007; 120(4): 898 - 921.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
JOURNAL WATCH PEDIATRICS & ADOLESCENT MEDICINE
Arch. Dis. Child., July 1, 2006; 91(7): 618 - 619.
[Full Text] [PDF]

Home page
 JWatch PediatricsHome page
Cochlear Implants Increase Meningitis Risk
Journal Watch Pediatrics and Adolescent Medicine, April 7, 2006; 2006(407): 2 - 2.
[Full Text]